Resource Summary

Clinical Question:
Are the benefits worth the risks of ASA in primary prevention (patients with no history of cardiovascular disease (CVD))?

The majority of primary prevention patients will not benefit from daily ASA therapy. It is possible that there is net benefit in higher-risk primary prevention patients. Although the best risk level to initiate ASA is uncertain^ it may be those with a ≥15-20 percent risk of CVD over 10 years.

*** Original Documents can be found and downloaded using the link provided below ***

Publication Date: 2013-7-22
Last Updated on PCR: 2017-03-31 15:13:52